Added value of [ 18 F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.

Jacques DarcourtDavid ChardinVéronique BourgJocelyn GalRenaud SchiappaMarie BlonskiPierre-Malick KoulibalyFabien AlmairacLydiane MondotFlorence Le JeuneLaurent CollombierAurélie KasLuc TaillandierAntoine Verger

Published in: European journal of nuclear medicine and molecular imaging (2023)

F]FDOPA PET adds significant information for the follow-up of HGG patients in clinical practice. When MRI findings are not straightforward, it can change the management for more than 20% of the patients and increases the confidence level of the multidisciplinary board decisions.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
high grade
computed tomography
prognostic factors
peritoneal dialysis
clinical practice
magnetic resonance imaging
magnetic resonance
contrast enhanced
patient reported outcomes
low grade
positron emission tomography